| Zacks Company Profile for AtriCure, Inc. (ATRC : NSDQ) |
|
|
| |
| • Company Description |
| AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as a standard treatment alternative during open-heart surgical procedures to safely, rapidly and reliably create lesions in cardiac, or heart, tissue to block the abnormal electrical impulses that cause atrial fibrillation, a quivering of the upper chambers of the heart.
Number of Employees: 1,300 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $32.06 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 364,105 shares |
| Shares Outstanding: 49.51 (millions) |
| Market Capitalization: $1,587.13 (millions) |
| Beta: 1.56 |
| 52 Week High: $43.11 |
| 52 Week Low: $20.20 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
-0.84% |
-4.55% |
| 12 Week |
0.16% |
-15.76% |
| Year To Date |
4.91% |
-1.75% |
|
|
|
|
| |
|
|
| |
| • General Corporate Information |
Officers
Michael H. Carrel - President; Chief Executive Officer and Director
Robert S. White - Chairman
Regina E. Groves - Director
B. Kristine Johnson - Director
Shlomo Nachman - Director
|
|
Peer Information
AtriCure, Inc. (BJCT)
AtriCure, Inc. (CADMQ)
AtriCure, Inc. (APNO)
AtriCure, Inc. (UPDC)
AtriCure, Inc. (IMTIQ)
AtriCure, Inc. (CYGN)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 04963C209
SIC: 3841
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 07/29/25
|
|
Share - Related Items
Shares Outstanding: 49.51
Most Recent Split Date: (:1)
Beta: 1.56
Market Capitalization: $1,587.13 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.00% |
| Current Fiscal Quarter EPS Consensus Estimate: $-0.14 |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $-0.50 |
Payout Ratio: |
| Number of Estimates in the Fiscal Year Consensus: 4.00 |
Change In Payout Ratio: |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: 07/29/25 |
|
|
|
| |
